Skip to main content
Clinical Trials/NCT03816111
NCT03816111
Active, not recruiting
Not Applicable

A Pragmatic, Registry-based, International, Cluster-randomized Controlled Trial Examining the Use of TEACH-PD Training Modules for Incident PD Patients Versus Existing Practices on the Rate of PD-related Infections

The University of Queensland48 sites in 2 countries1,500 target enrollmentJuly 22, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Kidney Disease, Chronic
Sponsor
The University of Queensland
Enrollment
1500
Locations
48
Primary Endpoint
Time to the first occurrence of any PD-related infection
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

For many patients peritoneal dialysis (PD) is the preferred form of dialysis to treat kidney disease as it provides greater flexibility and the ability to dialyse at home. However, PD use in Australia has been decreasing over the last 10 years. A big reason for this drop is the risk of infection. The best way to prevent PD related infections is to make sure that patients have good training in PD techniques. The researchers of this study have developed TEACH-PD, a new education package for training both PD nurses and PD patients.

The aim of this study is to find out whether TEACH-PD training reduces the number of PD related infections.

Detailed Description

End stage kidney disease is fatal unless treated with dialysis or transplant. Peritoneal dialysis (PD) is a core dialysis modality offering home-based care for patients. PD utilization is frequently threatened beyond 5 years for most patients due to PD-related infections. Patient training is a critical cornerstone of mitigating infection risk and maximizing PD durability (technique survival), but training practices are characterized by a lack of standardization and severe heterogeneity. There is no high-level evidence to inform PD training. Accordingly, a structured program encompassing how and what to teach PD patients at the inception of PD treatment has the potential to reduce serious PD-related infections, extend the longevity of PD, support cost-effective home-based dialysis care, and reduce costs and health service utilization associated with hospitalization and transition to haemodialysis. TEACH-PD is a standardised modular curriculum for both PD nurse trainers and patients that has been collaboratively developed by renal nurses, doctors, educationalists and patients, aligned to current International Society for Peritoneal Dialysis (ISPD) guidelines, utilizing modern adult learning principles. The TEACH-PD program is feasible and acceptable, as demonstrated in a successful pilot study. The primary objective of TEACH-PD CRCT (Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes - a Cluster Randomised Controlled Trial) is to determine whether implementation of standardised training modules based on ISPD guidelines targeting both PD trainers and patients results in a longer time to the composite end-point of exit site infections, tunnel infections and peritonitis in incident PD patients compared to existing training practices. TEACH-PD is a registry-based, pragmatic, multi-center, multinational trial, randomising PD units to implementing TEACH-PD training modules targeted at PD trainers and incident PD patients versus standard existing practices. An estimated 1,500 patient new to PD will be recruited from at least approximately 42-44 PD units in Australia and New Zealand.The study is being coordinated by the University of Queensland (operating through the Australasian Kidney Trial Network). The TEACH-PD training modules have been developed by a core group of renal nurses from the HOME Network in conjunction with senior medical clinicians from the Australasian Kidney Trials Network, eLearning curriculum developers, consumer representatives, and education experts, in line with the ISPD guidelines, utilizing modern adult learning principles and best practice eLearning techniques. The modules will be implemented at PD units in Australia and New Zealand to formally evaluate whether, compared with standard care, a standardised training curriculum will reduce the rate of PD-related infections and improve technique survival, resulting in better outcomes for patients receiving PD and significant cost-savings to the community.

Registry
clinicaltrials.gov
Start Date
July 22, 2019
End Date
April 30, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients new to PD;
  • Patients \> 18 years of age,
  • Need to undergo PD training;
  • Are able to provide informed consent

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Time to the first occurrence of any PD-related infection

Time Frame: From the PD start date until first PD-related infection, assessed up to 4 years

Time to the first occurrence of any PD-related infection including exit site infection, tunnel infection or peritonitis

Secondary Outcomes

  • Time to first exit site infection(From the PD start date until first exit site infection, assessed up to 4 years)
  • Time to first episode of peritonitis(From the PD start date until first peritonitis episode, assessed up to 4 years)
  • Participant Quality of Life questionnaire(Completed at baseline, 6, 12, 18 and 24 months)
  • Time to first tunnel infection(From the PD start date until first tunnel infection, assessed up to 4 years)
  • Time to infection-associated catheter removal(From the PD start date until first infection-associated catheter removal, assessed up to 4 years)
  • Incidence of technique failure - 180 days(Assessed at 180 days after transfer to HD or if death occurs within this period)
  • Incidence of technique failure - 30 days(Assessed at 30 days after transfer to HD or if death occurs within this period)
  • Incidence of all-cause hospitalization(Assessed from the PD start date, over up to 4 years)
  • Incidence of all-cause mortality(Assessed from the PD start date, over up to 4 years)
  • Health-care cost-effectiveness analysis(Assessed from the PD start date, over up to 4 years)

Study Sites (48)

Loading locations...

Similar Trials